One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: This study investigates the effects of dapagliflozin on the visceral adiposity index (VAI), lipid accumulation product (LAP), product of triglycerides and glucose (TyG) and triglycerides to HDL-cholesterol ratio (TG/HDL-C) in patients with type 2 diabetes mellitus (T2D). METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Radellini, Stefano, Vigneri, Enrica, Guarnotta, Valentina, Panto, Felicia, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179882/
https://www.ncbi.nlm.nih.gov/pubmed/33928530
http://dx.doi.org/10.1007/s13300-021-01056-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179882/
https://www.ncbi.nlm.nih.gov/pubmed/33928530
http://dx.doi.org/10.1007/s13300-021-01056-4

Ejemplares similares